2024/04/27 更新

写真a

キムラ ナルヒロ
木村 成宏
KIMURA Naruhiro
所属
医歯学総合病院 消化器内科 特任助教
職名
特任助教
通称等の別名
新潟大学医歯学総合病院消化器内科
外部リンク

学位

  • 医学博士 ( 2017年   新潟大学 )

研究分野

  • ライフサイエンス / 消化器内科学

経歴

  • 新潟大学   医歯学総合研究科   特任助教

    2022年9月 - 2024年3月

  • 新潟大学   医歯学総合病院 消化器内科   特任助教

    2024年4月 - 現在

 

論文

  • A rare cause of esophageal stenosis: Compression due to a thoracic osteophyte. 国際誌

    Suguru Miida, Yoshihisa Arao, Nobutaka Takeda, Shu Goto, Yuichi Kojima, Naruhiro Kimura, Kazunao Hayashi, Atsunori Tsuchiya, Shuji Terai

    DEN open   4 ( 1 )   e260   2024年4月

     詳細を見る

    記述言語:英語  

    Several cases of esophageal stenosis caused by cervical vertebral osteophytes have been reported; however, few reports of esophageal stenosis caused by thoracic osteophytes are available. We describe the case of an 86-year-old man with esophageal stenosis caused by a thoracic osteophyte near the tracheal bifurcation. An endoscopic ultrasonography examination was scheduled to determine the cause of acute pancreatitis; however, lacerations observed at the bifurcation following endoscope removal during prior esophagogastroduodenoscopy led us to cancel the ultrasonography to avoid potential esophageal perforation. A review of the present case and six similar previous cases of thoracic osteophyte-associated esophageal stenosis (identified via a systematic search of the PubMed database) demonstrated the clinical importance of a thoracic osteophyte near physiological esophageal stenosis. Esophagogastroduodenoscopy and computed tomography should be performed to screen for vertebral osteophytes before endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography, and transesophageal echocardiography to avoid iatrogenic accidents.

    DOI: 10.1002/deo2.260

    PubMed

    researchmap

  • Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis. 国際誌

    Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Yusuke Horibata, Yusuke Kaneko, Haruka Miyazaki, Kohei Ogawa, Yuzo Kawata, Norihiro Sakai, Yusuke Watanabe, Hiroyuki Abe, Hiroteru Kamimura, Akira Sakamaki, Takeshi Yokoo, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai

    Hepatology research : the official journal of the Japan Society of Hepatology   2023年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIMS: Ursodeoxycholic acid is the first-line treatment for primary biliary cholangitis, and treatment response is one of the factors predicting the outcome. To prescribe alternative therapies, clinicians might need additional information before deciphering the treatment response to ursodeoxycholic acid, contributing to a better patient prognosis. In this study, we developed and validated machine learning (ML) algorithms to predict treatment responses using pretreatment data. METHODS: This multicenter cohort study included collecting datasets from two data samples. Data 1 included 245 patients from 18 hospitals for ML development, and was divided into (i) training and (ii) development sets. Data 2 (iii: test set) included 51 patients from our hospital for validation. An extreme gradient boosted tree predicted the treatment response in the ML model. The area under the curve was used to evaluate the efficacy of the algorithm. RESULTS: Data 1 showed that patients complying with the Paris II treatment response had significantly lower serum alkaline phosphatase and total bilirubin levels than those who did not respond. Three factors, total bilirubin, total protein, and alanine aminotransferase levels were selected as essential variables for prediction. Data 2 showed that patients complying with the Paris II criteria had significantly high prothrombin time and low total bilirubin levels. The area under the curve of extreme gradient boosted tree was good for (ii) (0.811) and (iii) (0.856). CONCLUSIONS: We demonstrated the efficacy of ML in predicting the treatment response for patients with primary biliary cholangitis. Early identification of cases requiring additional treatment with our novel ML model may improve prognosis.

    DOI: 10.1111/hepr.13966

    PubMed

    researchmap

  • Machine learning prediction model for treatment responders in patients with primary biliary cholangitis. 国際誌

    Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Shu Goto, Suguru Miida, Nobutaka Takeda, Yuichi Kojima, Yoshihisa Arao, Kazunao Hayashi, Norihiro Sakai, Yusuke Watanabe, Hiroyuki Abe, Hiroteru Kamimura, Akira Sakamaki, Takeshi Yokoo, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai

    JGH open : an open access journal of gastroenterology and hepatology   7 ( 6 )   431 - 438   2023年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND AIM: Treatment response to ursodeoxycholic acid may predict the prognosis of patients with primary biliary cholangitis (PBC). Recent studies have suggested the benefits of using machine learning (ML) to forecast complex medical predictions. We aimed to predict treatment response in patients with PBC using ML and pretreatment data. METHODS: We conducted a single-center retrospective study and collected data from 194 patients with PBC who were followed up for at least 12 months after treatment initiation. Patient data were analyzed with five ML models, namely random forest, extreme gradient boosting (XGB), decision tree, naïve Bayes, or logistic regression, to predict treatment response using the Paris II criteria. The established models were assessed using an out-of-sample validation. The area under the curve (AUC) was used to evaluate the efficacy of each algorithm. Overall survival and liver-related deaths were analyzed using Kaplan-Meier analysis. RESULTS: Compared to logistic regression (AUC = 0.595, P = 0.0219, 0.031 models), ML analyses showed significantly high AUC in the random forest (AUC = 0.84) and XGB (AUC = 0.83) models; however, the AUC was not significantly high for decision tree (AUC = 0.633) or naïve Bayes (AUC = 0.584) models. Kaplan-Meier analysis showed significantly improved prognoses in patients predicted to achieve the Paris II criteria by XGB (log-rank = 0.005 and 0.007). CONCLUSION: ML algorithms could improve treatment response prediction using pretreatment data, which could lead to better prognoses. In addition, the ML model using XGB could predict the prognosis of patients before treatment initiation.

    DOI: 10.1002/jgh3.12915

    PubMed

    researchmap

  • NASHメダカモデルにおける老化細胞除去剤としてのダサチニブ及びケルセチンの有用性に関する検証

    阿部 寛幸, 弥久保 俊太, 酒井 規裕, 木村 成宏, 坂牧 僚, 土屋 淳紀, 上村 顕也, 寺井 崇二

    肝臓   64 ( Suppl.1 )   A364 - A364   2023年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • FDA,PMDAデータベース20年の副作用報告から報告形態による国際比較の解析

    上村 博輝, 酒井 規裕, 木村 成宏, 薛 徹, 土屋 淳紀, 寺井 崇二

    肝臓   64 ( Suppl.1 )   A412 - A412   2023年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019. 国際誌

    Hiroteru Kamimura, Toru Setsu, Naruhiro Kimura, Makoto Miyazawa, Shota Kaneko, Kenya Kamimura, Atsunori Tsuchiya, Yoshihiro Uesawa, Shuji Terai

    Hepatology research : the official journal of the Japan Society of Hepatology   53 ( 6 )   556 - 568   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: This study aimed to analyze the current trends of drug-induced liver-related adverse events in the Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases. METHODS: The characteristics of implicated drugs were investigated by analyzing big data on drug-induced liver-related adverse events over the past 20 years in FAERS, comparing drug rankings between the JADER and FAERS databases, and calculating rankings of drugs inducing liver-related adverse events using the Medical Dictionary for Regulatory Activities Terminology. RESULTS: In the 452,272 cases registered in FAERS from 1997 to 2019, warfarin, paracetamol, and adalimumab were the drugs most related to DILI. In the 38,919 cases registered in the JADER from 2004 to 2019, sorafenib, nivolumab, and herbal extracts were the drugs most related to DILI. No associations were found between the top 30 drugs in either of the two databases. Notably, the number of drug-induced liver-related adverse event reports and total adverse events has sharply increased in recent years. CONCLUSIONS: Although liver-related adverse events are largely caused by host immunity and other constitutional factors, differences in primary diseases, countries, and historical backgrounds lead to differences in the number of reports. Securing an appropriate database and a mechanism to collect real-time information on the frequency of adverse drug reactions is warranted. This article is protected by copyright. All rights reserved.

    DOI: 10.1111/hepr.13883

    PubMed

    researchmap

  • Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice. 国際誌

    Yusuke Watanabe, Hiroyuki Abe, Naruhiro Kimura, Yoshihisa Arao, Natsuki Ishikawa, Maeda Yuichiro, Toru Setsu, Akira Sakamaki, Hiroteru Kamimura, Takeshi Yokoo, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai

    Hepatology research : the official journal of the Japan Society of Hepatology   53 ( 5 )   460 - 472   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: Acute-on-chronic liver failure (ACLF), a disease with poor prognosis, is reportedly caused by cellular senescence due to mitochondrial dysfunction. In this study, we described and analyzed the underlying mechanism of a novel approach for ACLF using ABT263/navitoclax (Navi) that selectively eliminates senescent cells. METHODS: Irradiation-induced senescent hepatocytes were used for in vitro evaluation of the effects of Navi on ACLF (n = 6 for each group). Lipopolysaccharide- and carbon tetrachloride-induced ACLF mouse model was used for in vivo evaluation of the effects of Navi administration compared with the control using one-way or two-way analysis of variance, followed by Student's t-test or Kruskal-Wallis test. The effects on the senescence-associated secretory phenotype (n = 8 for each group) and mitochondrial functions, including adenosine triphosphate concentration and membrane potential (n = 8 for each group), were investigated using real-time polymerase chain reaction, immunohistochemistry, and enzyme analysis. RESULTS: Navi eliminated irradiation-induced senescent hepatocytes in vitro, leading to non-senescent hepatocyte proliferation. Navi eliminated senescent cells in the liver in vivo, resulting in downregulation of mRNA expression of senescence-associated secretory phenotype factors, a decrease of liver enzymes, and upregulated proliferation of non-senescent cells in the liver. Regarding mitochondrial functional assessment in the liver, adenosine triphosphate concentration and membrane potential were upregulated after Navi administration in vitro and in vivo. CONCLUSIONS: Navi may ameliorate ACLF damage by eliminating senescent cells in the liver, downregulating senescence-associated secretory phenotype factors, and upregulating mitochondrial functions. We believe that this novel approach using Navi will pave the way for ACLF treatment.

    DOI: 10.1111/hepr.13879

    PubMed

    researchmap

  • Edwardsiella tardaによる大量膿瘍をきたした肝硬変患者の1例 症例報告(Massive empyema with Edwardsiella tarda in a patient with liver cirrhosis: a case report)

    水戸 將貴, 木村 成宏, 山崎 華子, 神保 遼, 小島 雄一, 荒生 祥尚, 林 和直, 土屋 淳紀, 寺井 崇二

    日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集   71回・93回   47 - 47   2022年12月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • Two rare pancreatic parenchymal hemorrhagic lesions associated with acute pancreatitis in acute liver failure: a case report and literature review.

    Ryo Jimbo, Yoshihisa Arao, Atsunori Tsuchiya, Hanako Yamazaki, Masaki Mito, Yuichi Kojima, Yuji Kobayashi, Naruhiro Kimura, Kazunao Hayashi, Shuji Terai

    Clinical journal of gastroenterology   2022年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Acute pancreatitis is an uncommon occurrence in acute liver failure. Furthermore, such cases are rarely complicated by parenchymal hemorrhages. Herein, we report the case of a 69-year-old male patient with multiple pancreatic parenchymal hemorrhages concomitant with acute liver failure. The patient underwent conservative treatment for acute liver failure caused by hepatitis B virus infection. Plain computed tomography on the 30th day revealed two high-density mass lesions in the pancreatic body and tail, which were suspected to be multiple pancreatic parenchymal hemorrhages. Despite restarting gabexate mesylate, the patient died of multiple organ failure on the 49th day. The clinical information of the present case and our literature review of 61 similar cases in 43 case reports identified via a systematic keyword search of the PubMed database, which described acute pancreatitis concomitant with acute hepatitis and acute liver failure, will aid physicians in the diagnosis and treatment of this rare condition.

    DOI: 10.1007/s12328-022-01738-x

    PubMed

    researchmap

  • 慢性肝疾患におけるTGFβ3の発現と肝予備能との関連性についての検討

    阿部 寛幸, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 上村 博輝, 坂牧 僚, 横尾 健, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.2 )   A597 - A597   2022年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • アテゾリズマブ+ベバシズマブ併用療法の非奏効例におけるLate line移行時期についての検討

    横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.2 )   A582 - A582   2022年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 慢性肝疾患におけるTGFβ3の発現と肝予備能との関連性についての検討

    阿部 寛幸, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 上村 博輝, 坂牧 僚, 横尾 健, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.2 )   A597 - A597   2022年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • アテゾリズマブ+ベバシズマブ併用療法の非奏効例におけるLate line移行時期についての検討

    横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.2 )   A582 - A582   2022年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis. 国際誌

    Naruhiro Kimura, Toru Setsu, Yoshihisa Arao, Norihiro Sakai, Yusuke Watanabe, Hiroyuki Abe, Hiroteru Kamimura, Akira Sakamaki, Takeshi Yokoo, Kenya Kamimura, Atsunori Tsuchiya, Akihiko Osaki, Kentarou Igarashi, Nobuo Waguri, Masahiko Yanagi, Toru Takahashi, Soichi Sugitani, Yuka Kobayashi, Masaaki Takamura, Akira Yoshikawa, Toru Ishikawa, Toshiaki Yoshida, Toshiaki Watanabe, Hitoshi Bannai, Tomoyuki Kubota, Kazuhiro Funakoshi, Hiroto Wakabayashi, So Kurita, Norio Ogata, Masashi Watanabe, Yuhsaku Mita, Shigeki Mori, Motoya Sugiyama, Toru Miyajima, Sumio Takahashi, Shuichi Sato, Kisei Ishizuka, Hironobu Ohta, Yutaka Aoyagi, Shuji Terai

    JGH open : an open access journal of gastroenterology and hepatology   6 ( 8 )   577 - 586   2022年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background and Aim: Symptoms of primary biliary cholangitis (PBC) frequently impair one's quality of life (QOL). Nonetheless, with improved treatment, the prognosis of PBC also improves. QOL plays an important role in patients with PBC. In this study, we aimed to reevaluate the transition of new symptom development in PBC and its predictive factors. Methods: This retrospective multicenter study enrolled 382 patients with PBC for symptom analysis. The impact of a newly developed symptom on PBC prognosis was investigated by Kaplan-Meier analysis with propensity score matching and logistic progression analysis. Results: The cumulative risk of developing a new symptom after 10 and 20 years of follow-up was 7.6 and 28.2%, and specifically that of pruritus, which was the most common symptom, was 6.7 and 23.3%, respectively. In Cox hazard risk analysis, serum Alb level (hazard ratio [HR], 1.097; 95% confidence interval [CI], 1.033-1.165; P = 0.002), the serum D-Bil level (HR, 6.262; 95% CI, 2.522-15.553, P < 0.001), and Paris II criteria (HR, 0.435; 95% CI, 0.183-1.036; P = 0.037) were significant independent predictors of a new symptom. Kaplan-Meier analysis showed that the overall survival and liver-related death were not significant between patients with and without a new symptom. Conclusion: The cumulative risk of new symptom development is roughly 30% 20 years after diagnosis and could be predicted by factors including serum albumin levels, serum D-Bil level, and Paris II criteria.

    DOI: 10.1002/jgh3.12789

    PubMed

    researchmap

  • 機械学習を用いた慢性心不全に続発した肝臓への障害(Cardiac Hepatopathy)の画像解析

    三井田 秀, 上村 博輝, 山崎 文紗子, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 薛 徹, 横尾 健, 坂牧 僚, 土屋 淳紀, 藤木 伸也, 猪又 孝元, 寺井 崇二

    日本門脈圧亢進症学会雑誌   28 ( 3 )   152 - 152   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    researchmap

  • 機械学習を用いた慢性心不全に続発した肝臓への障害(Cardiac Hepatopathy)の画像解析

    三井田 秀, 上村 博輝, 山崎 文紗子, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 薛 徹, 横尾 健, 坂牧 僚, 土屋 淳紀, 藤木 伸也, 猪又 孝元, 寺井 崇二

    日本門脈圧亢進症学会雑誌   28 ( 3 )   152 - 152   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    researchmap

  • 肝性腹水が腹部コンパートメント症候群を介して腎機能へ与える影響の検討

    上村 博輝, 酒井 規裕, 小島 雄一, 川田 雄三, 渡邊 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 横尾 健, 坂牧 僚, 土屋 淳紀, 上村 顕也, 横山 純二, 寺井 崇二

    日本門脈圧亢進症学会雑誌   28 ( 2 )   199 - 203   2022年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    大量の肝性腹水が腹腔内圧の上昇をもたらし、腹部コンパートメント症候群を発症している状況を腹水前後の膀胱内圧測定、腎静脈流速測定を中心に検討した。対象症例は穿刺前後の膀胱内圧測定、腎静脈の流速測定等が可能であった腹水合併肝硬変8例。穿刺前後の膀胱内圧、尿潜血反応、腎機能、腎静脈流速等を経時的に観察した。末期肝硬変患者が肝腎症候群へ移行する過程で腹水による腹腔内圧の上昇が腎うっ血を併発させ、レニン-アンギオテンシン-アルドステロン系の亢進に関係する可能性が示唆された。(著者抄録)

    researchmap

  • 【肝性脳症の病態と治療】肝性脳症と腸内細菌 病態と治療

    坂牧 僚, 上村 顕也, 横山 邦彦, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 薛 徹, 阿部 寛幸, 上村 博輝, 横尾 健, 土屋 淳紀, 寺井 崇二

    消化器・肝臓内科   12 ( 1 )   68 - 72   2022年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 肝性腹水が腹部コンパートメント症候群を介して腎機能へ与える影響の検討

    上村 博輝, 酒井 規裕, 小島 雄一, 川田 雄三, 渡邊 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 横尾 健, 坂牧 僚, 土屋 淳紀, 上村 顕也, 横山 純二, 寺井 崇二

    日本門脈圧亢進症学会雑誌   28 ( 2 )   199 - 203   2022年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    大量の肝性腹水が腹腔内圧の上昇をもたらし、腹部コンパートメント症候群を発症している状況を腹水前後の膀胱内圧測定、腎静脈流速測定を中心に検討した。対象症例は穿刺前後の膀胱内圧測定、腎静脈の流速測定等が可能であった腹水合併肝硬変8例。穿刺前後の膀胱内圧、尿潜血反応、腎機能、腎静脈流速等を経時的に観察した。末期肝硬変患者が肝腎症候群へ移行する過程で腹水による腹腔内圧の上昇が腎うっ血を併発させ、レニン-アンギオテンシン-アルドステロン系の亢進に関係する可能性が示唆された。(著者抄録)

    researchmap

  • 多発性出血性膵炎を伴う重度の急性肝不全の一例(A case of severe acute liver failure with multiple hemorrhagic pancreatitis)

    神保 遼, 荒生 祥尚, 山崎 華子, 水戸 將貴, 小島 雄一, 木村 成宏, 小林 雄司, 林 和直, 土屋 淳紀, 寺井 崇二

    日本消化器病学会甲信越支部例会抄録集   70回   np41 - np41   2022年6月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • 多発性出血性膵炎を伴う重度の急性肝不全の一例(A case of severe acute liver failure with multiple hemorrhagic pancreatitis)

    神保 遼, 荒生 祥尚, 山崎 華子, 水戸 將貴, 小島 雄一, 木村 成宏, 小林 雄司, 林 和直, 土屋 淳紀, 寺井 崇二

    日本消化器病学会甲信越支部例会抄録集   70回   np41 - np41   2022年6月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • Relative Dose Intensityに基づく高齢者レンバチニブ投与における全生存期間の検討

    横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.1 )   A302 - A302   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Relative Dose Intensityに基づく高齢者レンバチニブ投与における全生存期間の検討

    横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    肝臓   63 ( Suppl.1 )   A302 - A302   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • Utility of autologous fecal microbiota transplantation and elucidation of microbiota in diversion colitis. 国際誌

    Kentaro Tominaga, Atsunori Tsuchiya, Takeshi Mizusawa, Asami Matsumoto, Ayaka Minemura, Kentaro Oka, Motomichi Takahashi, Tomoaki Yoshida, Yuichi Kojima, Kohei Ogawa, Yuzo Kawata, Nao Nakajima, Naruhiro Kimura, Hiroyuki Abe, Toru Setsu, Kazuya Takahashi, Hiroki Sato, Satoshi Ikarashi, Kazunao Hayashi, Ken-Ichi Mizuno, Junji Yokoyama, Yosuke Tajima, Masato Nakano, Yoshifumi Shimada, Hitoshi Kameyama, Toshifumi Wakai, Shuji Terai

    DEN open   2 ( 1 )   e63   2022年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Objectives: Diversion colitis (DC) is an inflammatory disorder caused by interruption of the fecal stream and subsequent nutrient deficiency from luminal bacteria. The utility of fecal microbiota transplantation (FMT) for DC was recently investigated; however, the precise pathogenesis of this condition remains unclear. This study aimed to evaluate the utility of autologous FMT in DC and to determine the related changes in the intestinal microbiota. Methods: Autologous FMT was performed to reestablish the intestinal microbiota in five patients (average age, 64.6 ± 8.3 years) with DC. They underwent double-ended colostomy. We assessed the diverted colon by endoscopy and evaluated the microbiota before and after FMT using the 16S rRNA gene sequencing method. Results: All five patients had mild inflammation (ulcerative colitis endoscopic index of severity [UCEIS] 2-3) in the diverted colon based on the colonoscopic findings. Three patients presented with symptoms, such as tenesmus, mucoid stool, and bloody stool. With FMT treatment, all patients achieved endoscopic remission (UCEIS score of 0 or 1) and symptomatic improvement. We observed a significantly decreased α-diversity in DC patients compared to healthy controls. The frequency of aerobic bacteria, such as Enterobacteriaceae, in the diverted colon decreased after autologous FMT. Conclusions: This study was the first to show that the microbiota in the diverted colon was significantly affected by autologous FMT. Since interruption of the fecal stream is central to the development of DC, FMT can be considered a promising treatment.

    DOI: 10.1002/deo2.63

    PubMed

    researchmap

  • 患者まで届いている再生医療 より効果のある肝硬変症に対する再生医療の実現を目指して

    寺井 崇二, 土屋 淳紀, 渡邊 雄介, 竹内 卓, 野尻 俊介, 酒井 規裕, 木村 成宏, 阿部 寛幸

    再生医療   21 ( 1 )   20 - 23   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本再生医療学会  

    肝硬変症に対する治療として、2003年実施した臨床研究:自己骨髄細胞投与療法により、肝線維化改善とそれに引き続く肝再生の誘導、それに伴う肝機能の改善効果を確認してきた。その後、2017年より、肝硬変症に対する他家脂肪組織由来間葉系幹細胞投与療法の企業治験、現在軽症の肝硬変に対する他家脂肪組織由来間葉系幹細胞の医師主導治験を2021年より実施している。さらに2020年よりHMGB1ペプチドを用いた医師主導治験を実施しており、より効率のいい再生療法の開発を行っている。さらに次のステップとして間葉系幹細胞由来エクソソームを用いた治療の準備を行っている。本稿では、現時点における我々の肝硬変症に対するアプローチを紹介する。(著者抄録)

    researchmap

  • Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis. 国際誌

    Akira Sakamaki, Masaaki Takamura, Norihiro Sakai, Yusuke Watanabe, Yoshihisa Arao, Naruhiro Kimura, Toru Setsu, Hiroyuki Abe, Takeshi Yokoo, Hiroteru Kamimura, Shunsuke Tsubata, Nobuo Waguri, Toru Ishikawa, Hirokazu Kawai, Soichi Sugitani, Tomomi Sato, Kazuhiro Funakoshi, Masashi Watanabe, Kentarou Igarashi, Kenya Kamimura, Atsunori Tsuchiya, Yutaka Aoyagi, Shuji Terai

    PloS one   17 ( 2 )   e0263464   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Due to the developments in the treatment for hepatitis, it is possible to prevent the progression of liver fibrosis and improve patients' prognosis even if it has already led to liver cirrhosis (LC). Consequently, a two-step study was conducted. To begin with, a retrospective study was conducted to identify the potential predictors of non-malignancy-related mortality from LC. Then, we prospectively analyzed the validity of these parameters as well as their association with patients' quality of life. In the retrospective study, 89 cases were included, and the multivariate Cox regression analysis indicated that age (P = 0.012), model for end-stage liver disease (MELD) score (P = 0.012), and annual rate of change of the albumin-bilirubin (ALBI) score (P < 0.001) were significantly associated with LC prognosis. In the prospective study, 70 patients were included, and the patients were divided into cirrhosis progression and non-progression groups. The univariate logistic regression analysis indicated the serum procollagen type III N-terminal peptide level (P = 0.040) and MELD score (P = 0.010) were significantly associated with the annual rate of change of the ALBI score. Furthermore, the mean Chronic Liver Disease Questionnaire score worsened from 5.3 to 4.9 in the cirrhosis progression group (P = 0.034). In conclusion, a longitudinal increase in the ALBI score is closely associated with non-malignancy-related mortality and quality of life.

    DOI: 10.1371/journal.pone.0263464

    PubMed

    researchmap

  • 胆管への浸潤を伴う胆管内乳頭状粘液性腺癌 1症例報告(Intraductal papillary mucinous adenocarcinoma with bile duct invasion: A case report)

    水戸 將貴, 戸田 遼, 木村 究, 小島 雄一, 小川 光平, 木村 成宏, 荒生 祥尚, 五十嵐 聡, 林 和直, 土屋 淳紀, 寺井 崇二, 加藤 卓, 味岡 洋一, 石川 博補, 滝沢 一泰, 若井 俊文

    日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集   69回・91回   53 - 53   2021年10月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • 原発性胆汁性胆管炎患者の予後を最もよく予想する治療反応性判定Criteriaについて

    木村 成宏, 高村 昌昭, 武田 信峻, 荒生 祥尚, 高綱 将史, 渡邉 雄介, 竹内 卓, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    日本消化器病学会雑誌   118 ( 臨増大会 )   A698 - A698   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 原発性胆汁性胆管炎患者の予後を最もよく予想する治療反応性判定Criteriaについて

    木村 成宏, 高村 昌昭, 武田 信峻, 荒生 祥尚, 高綱 将史, 渡邉 雄介, 竹内 卓, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    日本消化器病学会雑誌   118 ( 臨増大会 )   A698 - A698   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 胆管への浸潤を伴う胆管内乳頭状粘液性腺癌 1症例報告(Intraductal papillary mucinous adenocarcinoma with bile duct invasion: A case report)

    水戸 將貴, 戸田 遼, 木村 究, 小島 雄一, 小川 光平, 木村 成宏, 荒生 祥尚, 五十嵐 聡, 林 和直, 土屋 淳紀, 寺井 崇二, 加藤 卓, 味岡 洋一, 石川 博補, 滝沢 一泰, 若井 俊文

    日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集   69回・91回   53 - 53   2021年10月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • 急性膵炎後の膵仮性嚢胞門脈瘻による広範な門脈血栓症を発症した2例

    木村 成宏, 林 和直, 土屋 淳紀, 寺井 崇二

    日本門脈圧亢進症学会雑誌   27 ( 3 )   147 - 147   2021年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    researchmap

  • 門脈圧亢進症と臓器相関 心、肝、肺、腎、脾 当院における心不全に伴う肝臓への影響(Cardiac Hepatopathy)の解析

    上村 博輝, 寺井 崇二, 猪又 孝文, 三井田 秀, 山崎 文紗子, 柏村 健, 藤木 信也, 渡邊 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 坂牧 僚, 横尾 健

    日本門脈圧亢進症学会雑誌   27 ( 3 )   109 - 109   2021年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本門脈圧亢進症学会  

    researchmap

  • 高齢者消化器がん化学療法〜高齢者のがん治療を安全・効果的に遂行するための取り組み 高齢肝細胞癌症例における分子標的治療薬の生存期間延長効果と予測因子の検討

    横尾 健, 酒井 規裕, 渡邉 雄介, 荒生 祥尚, 木村 成宏, 阿部 寛幸, 薛 徹, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 寺井 崇二

    日本高齢消化器病学会誌   24 ( 1 )   115 - 115   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本高齢消化器病学会  

    researchmap

  • 感染性被包化と壊死門脈瘻を伴う膵仮性嚢胞の一例(A case of pancreatic pseudocyst-portal vein fistula with infected walled off necrosis)

    前田 悠一郎, 林 和直, 戸田 遼, 若林 拓哉, 木村 究, 水戸 將貴, 小島 雄一, 小川 光平, 荒生 祥尚, 木村 成宏, 五十嵐 聡, 土屋 淳紀, 徳永 麻美, 佐藤 知巳, 寺井 崇二

    日本消化器病学会甲信越支部例会抄録集   68回   35 - 35   2021年6月

     詳細を見る

    記述言語:英語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan. 国際誌

    Naruhiro Kimura, Masaaki Takamura, Nobutaka Takeda, Yusuke Watanabe, Yoshihisa Arao, Masahumi Takatsuna, Suguru Takeuchi, Hiroyuki Abe, Toru Setsu, Hiroteru Kamimura, Akira Sakamaki, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai

    Hepatology international   15 ( 2 )   437 - 443   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Biochemical response to treatment in patients with primary biliary cholangitis (PBC) reflects prognosis. However, the best predictive criteria to detect biochemical response remain undetermined. In addition, because these criteria need > 6 months until definition, parameters that can estimate its results before initiating treatment are needed. METHODS: We conducted a single-center retrospective study on 196 patients with PBC, followed up for at least 12 months after initiating treatment. RESULTS: Kaplan-Meier analysis showed that Paris II (p = 0.002) and Rotterdam criteria (p = 0.001) could estimate the overall survival of PBC patients, whereas Paris II (p = 0.001), Rotterdam (p = 0.001), and Rochester criteria (p= 0.025) could estimate liver-related deaths. Cox hazard analysis revealed Paris II and Rotterdam criteria as significantly independent predictors of overall survival (hazard ratio (HR) 3.948, 95% CI 1.293-12.054, p = 0.016 and HR 6.040, 95% CI 1.969-18.527, p = 0.002, respectively) and liver-related deaths (HR 10.461, 95% CI 1.231-88.936, p = 0.032 and HR 10.824, 95% CI 1.252-93.572, p = 0.032, respectively). The results of Paris II criteria could be estimated by serum prothrombin time (Odds ratio (OR) 1.052, 95% CI 1.008-1.098, p = 0.021) and alanine transaminase level (OR 0.954, 95% CI 0.919-0.991, p = 0.014) whereas, those of Rotterdam criteria could be estimated by serum albumin level (OR 3.649, 95% CI 1.098-12.128, p = 0.035) at the time of diagnosis. CONCLUSIONS: This study highlights the best prediction criteria and pre-treatment parameters that facilitate the prognosis of PBC patients.

    DOI: 10.1007/s12072-021-10163-0

    PubMed

    researchmap

  • Changes in disease characteristics of primary biliary cholangitis: An observational retrospective study from 1982 to 2016. 国際誌

    Masaaki Takamura, Yasunobu Matsuda, Naruhiro Kimura, Masafumi Takatsuna, Toru Setsu, Atsunori Tsuchiya, Akihiko Osaki, Nobuo Waguri, Masahiko Yanagi, Toru Takahashi, Soichi Sugitani, Yuka Kobayashi, Akira Yoshikawa, Toru Ishikawa, Toshiaki Yoshida, Toshiaki Watanabe, Hitoshi Bannai, Tomoyuki Kubota, Kazuhiro Funakoshi, Hiroto Wakabayashi, So Kurita, Norio Ogata, Masashi Watanabe, Yuhsaku Mita, Shigeki Mori, Motoya Sugiyama, Toru Miyajima, Sumio Takahashi, Shuichi Sato, Kisei Ishizuka, Hironobu Ohta, Yutaka Aoyagi, Shuji Terai

    Hepatology research : the official journal of the Japan Society of Hepatology   51 ( 2 )   166 - 175   2021年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: Disease characteristics of primary biliary cholangitis have changed recently. However, detailed studies on the subject have been limited. Therefore, we aimed to clarify disease characteristics of patients with recent primary biliary cholangitis using the cohort from Niigata University and 21 affiliated hospitals. METHODS: Overall, 508 patients were enrolled in this study from 1982 to 2016, divided into three cohorts according to their year of diagnosis: ≤1999, 2000-2009 and ≥2010. We compared differences in clinical characteristics, response to ursodeoxycholic acid and prognosis. RESULTS: The male-to-female ratio increased incrementally from 1:16.4 (≤1999) to 1:3.8 (≥2010) (P < 0.001). In women, the median age at diagnosis increased incrementally from 54.0 years (≤1999) to 60.5 years (≥2010) (P < 0.001) and serum albumin decreased gradually (P = 0.001), which might have affected the increase in the Fibrosis-4 Index and albumin-bilirubin score. The ursodeoxycholic acid response rate according to the Barcelona criteria increased incrementally from 26.7% (≤1999) to 78.4% (≥2010) (P < 0.010), and those according to other criteria (Paris-I, Rotterdam and Toronto) were approximately ≥80% in all cohorts. Ten-year survival rate in the ≤1999 and 2000-2009 cohorts were 98.6% and 95.6%, respectively. These earlier cohorts were also characterized by a higher rate of asymptomatic state and mild histology (83.5% [≤1999] and 84.7% [2000-2009], and 93.6% [≤1999] and 91.1% [2000-2009]). CONCLUSIONS: Patients with primary biliary cholangitis were characterized by older age at diagnosis and an increase in male to female ratio as well as higher response rates of ursodeoxycholic acid and longer survival, resulting from the early recognition of primary biliary cholangitis.

    DOI: 10.1111/hepr.13586

    PubMed

    researchmap

  • Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography

    Nobutaka Takeda, Atsunori Tsuchiya, Kazuki Natsui, Yui Ishii, Yoshihisa Arao, Naruhiro Kimura, Kentaro Tominaga, Suguru Takeuchi, Kazunao Hayashi, Masaaki Takamura, Shuji Terai

    CASE REPORTS IN GASTROENTEROLOGY   15 ( 2 )   507 - 512   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Focal nodular hyperplasia (FNH) is the second most frequent benign liver tumor, and it is a fiber-rich stiff lesion. Typically, FNH can be diagnosed by imaging without biopsy. However, liver biopsy and diagnostic resection may be required to differentiate atypical FNH from other liver tumors, such as hepatocellular adenoma (HCA). Therefore, improved noninvasive diagnostic methods are needed. We experienced 2 cases where combination of magnetic resonance elastography (MRE) and gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) helped diagnose FNH. A 36-year-old woman and 17-year-old boy with liver tumors measuring 40 mm in diameter each showed hypointense nodule centers, indicating a central scar, surrounded by hyperintense signals during the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI. To rule out HCA, we performed MRE and liver biopsy. On MRE, the mean stiffness of the mass was 11.6 kPa (mean stiffness of the background liver was 1.7 kPa) and 11.1 kPa (mean stiffness of the background liver was 2.4 kPa) in the first and second patients, respectively. Histological examination of both specimens showed CK7-positive bile-ductular proliferations, abundant fibrous tissue, and few Ki-67-positive cells. Based on these results, we diagnosed these tumors as FNH. Combination of Gd-EOB-DTPA-enhanced MRI and MRE can evaluate the character and stiffness of lesion and help in the diagnosis of FNH.

    DOI: 10.1159/000516552

    Web of Science

    researchmap

  • Screening and follow-up of chronic liver diseases with understanding their etiology in clinics and hospitals. 国際誌

    Masahiro Ogawa, Atsunori Tsuchiya, Takayuki Watanabe, Toru Setsu, Naruhiro Kimura, Masato Matsuda, Yoshiki Hoshiyama, Hiroaki Saito, Tsutomu Kanazawa, Motoi Shiotani, Tatsuhiko Sato, Takuya Yagi, Koji Igarashi, Norihiko Yoshimura, Masaaki Takamura, Hidefumi Aoyama, Shuji Terai

    JGH open : an open access journal of gastroenterology and hepatology   4 ( 5 )   827 - 837   2020年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background and Aim: Considering the increasing prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH), the development of an effective screening and follow-up system that enables the recognition of etiological changes by primary physicians in clinics and specialists in hospitals is required. Methods: Chronic hepatitis B (HBV) and C (HCV), NASH, and alcoholic steatohepatitis (ASH) patients who were assayed for Mac-2-binding protein glycosylation isomer (M2BPGi) (n = 272) and underwent magnetic resonance elastography (MRE) (n = 119) were enrolled. Patients who underwent MRE were also tested by ultrasound elastography (USE) (n = 80) and for M2BPGi (n = 97), autotaxin (ATX) (n = 62), and platelet count (n = 119), and their fibrosis-4 (FIB-4) index was calculated (n = 119). Results: FIB-4 index >2, excluding HBV-infected patients, M2BPGi >0.5, ATX >0.5, and platelet count <20 × 104/μL were the benchmark indices, and we took into consideration other risk factors, such as diabetes mellitus and age, to recommend further examinations, such as USE, based on the local situation to avoid overlooking hepatocellular carcinoma (HCC) in the clinic. During specialty care in the hospital, MRE exhibited high diagnostic ability for fibrosis stages >F3 or F4; it could efficiently predict collateral circulation with high sensitivity, which can replace USE. We also identified etiological features and found that collateral circulation in NASH/ASH patients tended to exceed high-risk levels; moreover, these patients exhibited more variation in HCC-associated liver stiffness than the HBV and HCV patients. Conclusions: Using appropriate markers and tools, we can establish a stepwise, practical, noninvasive, and etiology-based screening and follow-up system in primary and specialty care.

    DOI: 10.1002/jgh3.12406

    PubMed

    researchmap

  • Effectiveness of Endoscopic Pancreatic Stenting for Pancreatic Pseudocyst-Portal Vein Fistula

    Atsushi Kimura, Kazunao Hayashi, Chiyumi Oda, Kazunori Hosaka, Naruhiro Kimura, Kentaro Tominaga, Satoshi Ikarashi, Atsunori Tsuchiya, Shuji Terai

    CASE REPORTS IN GASTROENTEROLOGY   14 ( 3 )   570 - 576   2020年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Pancreatic pseudocyst-portal vein (PP-PV) fistula, mostly occurring after pseudocyst formation following acute/chronic pancreatitis, is a rare but life-threatening condition. The majority of treatments are based on conservative or surgical interventions. We report the case of a 70-year-old man with a PP-PV fistula and PV thrombosis. We adopted conservative treatment at first due to his mild symptoms. However, after resuming food intake, the patient had severe abdominal pain. Following endoscopic retrograde cholangiopancreatography, we found that the pseudocyst was connected with the PV through the fistula. Subsequently, an endoscopic nasopancreatic drainage (ENPD) catheter was inserted into the main pancreatic duct to establish pancreatic drainage, which resulted in a decrease in the abdominal pain. After the ENPD tube had been exchanged for endoscopic pancreatic stenting, his abdominal pain did not recur. Therefore, this case demonstrated endoscopic treatment as an effective treatment option for PP-PV fistula.

    DOI: 10.1159/000510331

    Web of Science

    researchmap

  • Visceral adipose tissue index and hepatocellular carcinoma are independent predictors of outcome in patients with cirrhosis having endoscopic treatment for esophageal varices. 査読 国際誌

    Naruhiro Kimura, Atsunori Tsuchiya, Chiyumi Oda, Atsushi Kimura, Kazunori Hosaka, Kentaro Tominaga, Kazunao Hayashi, Junji Yokoyama, Shuji Terai

    Digestive diseases (Basel, Switzerland)   39 ( 1 )   58 - 65   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The relationship between the amount of adipose tissue and advanced-stage liver cirrhosis with esophageal varices (EV) is unknown. We aimed to reveal the prognostic significance of adipose tissues in patients with liver cirrhosis. METHODS: We enrolled 87 patients with EV who received initial endoscopic treatment and underwent scheduled treatments in our hospital. Computed tomography (CT) images were obtained of a 5-mm slice at the umbilical level. We evaluated the effect of mortality based on the visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), and visceral subcutaneous adipose tissue ratio (VSR). RESULTS: Cox hazard multivariate analysis showed that the presence of hepatocellular carcinoma (HCC; hazard ratio [HR]: 4.650, 95% confidence interval [CI]: 1.750-12.353, P = 0.002), γ-GTP (HR: 1.003, 95% CI: 1.001-1.006, P = 0.026) and VATI (HR: 1.057, 95% CI: 1.030-1.085, P < 0.001) significantly affected mortality. Cox hazard multivariate analysis for liver-related death was also significantly affected by HCC (HR: 1.057, 95% CI: 1.030-1.085, P < 0.001) and VATI (HR: 1.052, 95% CI: 1.019-1.086, P = 0.002). The difference between the Child-Pugh scores 12 months post-treatment and that during initial treatment were significantly positively correlated with VATI (r = 0.326, P = 0.027). Patients with high VSR had a significantly higher frequency of HCC after EV treatment by Kaplan-Meier analysis (P = 0.024). CONCLUSION: Our findings suggest that VATI measured by CT could significantly predict mortality in cirrhosis patients through decreasing liver function and increasing HCC frequency and appropriately controlling VATI could improve their prognosis.

    DOI: 10.1159/000508867

    PubMed

    researchmap

  • Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient. 査読

    Naruhiro Kimura, Atsunori Tsuchiya, Chiyumi Oda, Atsushi Kimura, Kazunori Hosaka, Kentaro Tominaga, Kazunao Hayashi, Tatsuya Abé, Hajime Umezu, Shuji Terai

    Internal medicine (Tokyo, Japan)   59 ( 16 )   1971 - 1975   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 75-year-old woman with liver cirrhosis was admitted for treatment of portal vein thrombosis (PVT). Computed tomography (CT) showed PVT, massive ascites, and multiple abdominal organ embolism. Blood tests revealed a decreased liver function (Child-Pugh grade C). Language impairment followed by progressive left hemi-paralysis was subsequently detected. Magnetic resonance imaging revealed multiple small acute cerebral infarctions and, on CT, a 30-mm bladder tumour; a biopsy specimen examination showed squamous cell carcinoma. Her general condition worsened rapidly, and the best supportive care was chosen. Our findings suggest that, in patients with PVT, Trousseau syndrome should be considered, even in cases of liver cirrhosis.

    DOI: 10.2169/internalmedicine.4112-19

    PubMed

    researchmap

  • Esophageal Ulcers Associated with Ulcerative Colitis: A Case Series and Literature Review. 査読

    Kentaro Tominaga, Atsunori Tsuchiya, Hiroki Sato, Takeshi Mizusawa, Shinichi Morita, Yui Ishii, Nobutaka Takeda, Kazuki Natsui, Yuzo Kawata, Naruhiro Kimura, Yoshihisa Arao, Kazuya Takahashi, Kazunao Hayashi, Junji Yokoyama, Shuji Terai

    Internal medicine (Tokyo, Japan)   59 ( 16 )   1983 - 1989   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Ulcerative colitis, a chronic and recurrent inflammatory disease, is localized to the colonic mucosa but can affect other organs and lead to various complications. Gastroduodenitis associated with ulcerative colitis has been reported. However, little is known about esophageal ulcers. We herein report two rare cases of esophageal ulcers associated with ulcerative colitis. Furthermore, the clinical and histological characteristics of 18 previously reported cases are summarized. This case series and literature review will encourage the accurate diagnosis and treatment of esophageal ulcers associated with ulcerative colitis.

    DOI: 10.2169/internalmedicine.4437-20

    PubMed

    researchmap

  • Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. 査読 国際誌

    Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, Masaru Kumagai, Takeki Sato, Satoko Motegi, Yui Ishii, Youhei Koseki, Kei Tomiyoshi, Kazuki Natsui, Nobutaka Takeda, Yuki Yoshida, Fusako Yamazaki, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai

    Inflammation and regeneration   40   14 - 14   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide pandemic. The spread of the virus has had global effects such as activity restriction, economic stagnation, and collapse of healthcare infrastructure. Severe SARS-CoV-2 infection induces a cytokine storm, leading to acute respiratory distress syndrome (ARDS) and multiple organ failure, which are very serious health conditions and must be mitigated or resolved as soon as possible. Mesenchymal stem cells (MSCs) and their exosomes can affect immune cells by inducing anti-inflammatory macrophages, regulatory T and B cells, and regulatory dendritic cells, and can inactivate T cells. Hence, they are potential candidate agents for treatment of severe cases of COVID-19. In this review, we report the background of severe cases of COVID-19, basic aspects and mechanisms of action of MSCs and their exosomes, and discuss basic and clinical studies based on MSCs and exosomes for influenza-induced ARDS. Finally, we report the potential of MSC and exosome therapy in severe cases of COVID-19 in recently initiated or planned clinical trials of MSCs (33 trials) and exosomes (1 trial) registered in 13 countries on ClinicalTrials.gov.

    DOI: 10.1186/s41232-020-00121-y

    PubMed

    researchmap

  • Rare case of circumferential esophageal peeling 査読 国際誌

    Kentaro Tominaga, Atsunori Tsuchiya, Hiroki Sato, Yui Ishii, Nobutaka Takeda, Kazuki Natsui, Yuzo Kawata, Naruhiro Kimura, Yoshihisa Arao, Suguru Takeuchi, Kazunao Hayashi, Junji Yokoyama, Shuji Terai

    Clinical Case Reports   8 ( 7 )   1306 - 1308   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This report highlights the easy peeling of the esophageal epithelium with Nikolsky phenomenon after swallowing the foreign body and the healing status of the esophagus only 3 days later in a patient of pemphigus vulgaris.

    DOI: 10.1002/ccr3.2846

    Scopus

    PubMed

    researchmap

  • 肝硬度測定を用いたICG検査の代替の試み

    熊谷 優, 横尾 健, 佐藤 毅昂, 茂木 聡子, 川田 雄三, 薛 徹, 水野 研一, 木村 成宏, 上村 博輝, 坂牧 僚, 上村 顕也, 土屋 淳紀, 高村 昌昭, 寺井 崇二

    日本消化器病学会雑誌   116 ( 臨増大会 )   A849 - A849   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Usefulness of chemokine C-C receptor 7- /programmed cell death-1+ follicular helper T cell subset frequencies in the diagnosis of autoimmune hepatitis. 査読 国際誌

    Naruhiro Kimura, Satoshi Yamagiwa, Tomoyuki Sugano, Ryoko Horigome, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai

    Hepatology research : the official journal of the Japan Society of Hepatology   49 ( 9 )   1026 - 1033   2019年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIM: A significant concern for autoimmune hepatitis (AIH) patients is diagnostic specificity. Delayed treatment due to delayed diagnosis leads to poor survival. We recently reported that chemokine C-C receptor 7 (CCR7)- /programmed cell death-1 (PD-1)+ follicular helper T (Tfh) cells could be involved in AIH pathogenesis. We hypothesized that Tfh cell frequencies might contribute to AIH diagnosis. METHODS: Peripheral blood was collected from 12 patients with AIH from April 2013 to March 2016, as well as 24 patients with hepatitis B virus (HBV) infection and 44 healthy controls (HC). Mononuclear cells were separated using a Ficoll gradient, and surface markers were investigated using flow cytometry. RESULTS: The frequency of CCR7- PD-1+ Tfh cells was significantly higher in AIH patients (39.1 ± 8.6) compared to that in HC (25.1 ± 7.9%, P < 0.01) and HBV patients (22.7 ± 7.8, P < 0.01). The area under the receiver operating characteristic curve for the frequency of the CCR7- PD-1+ Tfh cell subset for AIH and HC and AIH and HBV was 0.905 and 0.927, respectively. The frequency of the CCR7- PD-1+ Tfh cell subset was not correlated with International Autoimmune Hepatitis Group (IAIHG) scoring, Simplified AIH scoring, or Japanese diagnostic guidelines (R = 0.10, 0.947; R = 0.0008, 0.180; and R = 0.348, 0.558, respectively). Therefore, these frequencies could diagnose AIH patients who were not diagnosed with the IAIHG or simplified AIH scores. CONCLUSIONS: The frequency of the peripheral CCR7- PD-1+ Tfh cell subset could be useful for diagnosing AIH even in patients who were not diagnosed with IAIHG or simplified AIH scores.

    DOI: 10.1111/hepr.13356

    PubMed

    researchmap

  • Epidemiological analysis of achalasia in Japan using a large-scale claims database. 査読

    Hiroki Sato, Hiroshi Yokomichi, Kazuya Takahashi, Kentaro Tominaga, Takeshi Mizusawa, Naruhiro Kimura, Yuzo Kawata, Shuji Terai

    Journal of gastroenterology   54 ( 7 )   621 - 627   2019年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Achalasia is a well-known esophageal motility disorder, but epidemiological studies in Japan are lacking. We investigated the incidence and period prevalence of achalasia in Japan, including the rate of coexistence of esophageal carcinoma, and evaluated treatment trends. METHODS: To estimate the nationwide number of patients with achalasia, a large-scale insurance claims database from 2005 to 2017 were used for our analyses. Patients with achalasia and coexistence of esophageal carcinoma were identified based on the diagnosis code registered. Interventional treatment was also evaluated. RESULTS: Of the total 5,493,650 populations, 385 were diagnosed with primary achalasia. The incidence was calculated as 0.81-1.37 per 100,000 person-years (male-to-female ratio was almost 1; mean age at diagnosis was 43.3 ± 14.4 years). The period prevalence was 7.0 per 100,000 persons. There were statistically significant trends of increase in the incidence and period prevalence over age groups (all p values < 0.0001). Four men with achalasia developed esophageal carcinoma, and the incidence of esophageal carcinoma with achalasia was estimated as 0.25 per 100 person-years. With regard to intervention, esophageal dilation was performed as a first treatment in 64.7% of patients, with repeat intervention required in 56.9% of these. The proportion of patients treated using peroral endoscopic myotomy (POEM) increased annually to 41.1% in 2017. CONCLUSIONS: In Japan, the incidence and period prevalence of achalasia is comparable to that in other countries. The absolute risk of esophageal carcinoma is rather low. Esophageal dilation has been the mainstay of achalasia treatment, and the role of POEM has increased annually.

    DOI: 10.1007/s00535-018-01544-8

    PubMed

    researchmap

  • Co-existent ulcerative colitis and Guillain-Barré syndrome: a case report and literature review. 査読

    Tominaga K, Tsuchiya A, Sato H, Kimura A, Oda C, Hosaka K, Kawata Y, Kimura N, Hayashi K, Yokoyama J, Terai S

    Clinical journal of gastroenterology   12 ( 3 )   243 - 246   2019年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s12328-019-00939-1

    PubMed

    researchmap

  • Utility of measuring paraesophageal varices using computed tomography to select endoscopic treatment for patients with esophageal varices. 査読

    Kimura N, Yokoyama J, Terai S

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society   31 ( 3 )   335   2019年5月

  • 当院における高齢発症原発性胆汁性胆管炎患者の予後予測マーカーについて

    高村 昌昭, 木村 成宏, 薛 徹, 上村 博輝, 坂牧 僚, 横尾 健, 土屋 淳紀, 上村 顕也, 松田 康伸, 寺井 崇二

    肝臓   60 ( Suppl.1 )   A407 - A407   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 当院における肝癌に対する放射線治療の検討

    柴田 理, 上村 顕也, 木村 成宏, 薛 徹, 横尾 健, 坂牧 僚, 上村 博輝, 土屋 淳紀, 高村 昌昭, 丸山 克也, 太田 篤, 海津 元樹, 青山 英史, 寺井 崇二

    日本消化器病学会雑誌   116 ( 臨増総会 )   A456 - A456   2019年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 高齢肝癌症例におけるソラフェニブの効果と有用性

    横尾 健, 森田 真一, 木村 成宏, 薛 徹, 坂牧 僚, 上村 博輝, 上村 顕也, 土屋 淳紀, 高村 昌昭, 寺井 崇二

    日本消化器病学会雑誌   116 ( 臨増総会 )   A413 - A413   2019年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma. 査読 国際誌

    Tsuchiya A, Ogawa M, Watanabe T, Takeuchi S, Kojima Y, Watanabe Y, Kimura N, Hayashi K, Yokoyama J, Terai S

    Heliyon   5 ( 3 )   e01325   2019年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.heliyon.2019.e01325

    PubMed

    researchmap

  • EpCAM- and/or NCAM-Expressing Hepatocellular Carcinoma in Which Behavior of Hepatic Progenitor Cell Marker-Positive Cells Are Followed. 査読

    Tsuchiya A, Suda T, Oda C, Kimura A, Hosaka K, Kimura N, Tominaga K, Hayashi K, Takamura M, Terai S

    Case reports in gastroenterology   13 ( 1 )   118 - 124   2019年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1159/000498913

    Web of Science

    PubMed

    researchmap

  • Different distribution of mucosal-associated invariant T cells within the human cecum and colon. 査読 国際誌

    Isamu Hama, Kentaro Tominaga, Satoshi Yamagiwa, Toru Setsu, Naruhiro Kimura, Hiroteru Kamimura, Toshifumi Wakai, Shuji Terai

    Central-European journal of immunology   44 ( 1 )   75 - 83   2019年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Introduction: Mucosal-associated invariant T (MAIT) cells are innate-like T cells that are involved in anti-bacterial immunity. MAIT cells are found in the intestines, but their role and distribution within the large intestine have not been fully elucidated. Therefore, we investigated the distribution of MAIT cells within the cecum and colon. Material and methods: Surgically resected tissues of the cecum and colon were obtained from 4 patients with cecal appendix cancer and 8 patients with colorectal cancer, respectively. Lymphocytes were isolated from the intestinal epithelium (intraepithelial lymphocytes - IELs) and the underlying lamina propria (lamina propria lymphocytes - LPLs), and then, MAIT cells were analyzed by flow cytometry. Results: Compared with the colon, the cecum showed a significantly increased frequency of MAIT cells among IELs (p < 0.01). CD69 expression on MAIT cells was significantly increased in the cecum and colon compared with that in the blood, and the frequency of natural killer group 2, member A+ cells among MAIT cells was significantly increased in the cecum. Conclusions: These results suggest that the distribution of MAIT cells was different between the cecum and colon and that MAIT cells were more likely to be activated, especially in the intestinal epithelium of the cecum than in the colon and blood.

    DOI: 10.5114/ceji.2019.84020

    PubMed

    researchmap

  • 腹部大動脈瘤増大により初めての腸閉塞をきたした腸回転異常症の高齢者の1例

    村松 夏季, 土屋 敦紀, 小田 知友美, 木村 淳史, 保坂 和徳, 木村 成宏, 冨永 顕太郎, 林 和直, 寺井 崇二

    日本消化器病学会甲信越支部例会抄録集   63回   74 - 74   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本消化器病学会-甲信越支部  

    researchmap

  • Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma. 査読 国際誌

    Tsuchiya A, Ogawa M, Watanabe Y, Kimura N, Hayashi K, Suda T, Terai S

    Clinical case reports   6 ( 8 )   1643 - 1644   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/ccr3.1674

    PubMed

    researchmap

  • A case of inferior vena cava thrombosis caused by compression due to growing giant liver cyst. 査読

    Kimura N, Tsuchiya A, Ogawa M, Watanabe Y, Hayashi K, Yokoyama J, Umezu H, Terai S

    Clinical journal of gastroenterology   12 ( 1 )   71 - 75   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s12328-018-0885-x

    PubMed

    researchmap

  • Renal Impairment in Chronic Hepatitis B: A Review. 査読 国際誌

    Hiroteru Kamimura, Toru Setsu, Naruhiro Kimura, Takeshi Yokoo, Akira Sakamaki, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Satoshi Yamagiwa, Shuji Terai

    Diseases (Basel, Switzerland)   6 ( 2 )   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The liver plays a key role in the metabolism of proteins. Liver dysfunction affects many organs because it communicates with the spleen and all digestive organs through the portal vein. Additionally, the kidney is an organ that is closely related to the liver and is involved in liver diseases. Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. Nucleos(t)ide analog (NA) therapy effectively suppresses HBV replication by inhibiting HBV polymerase, thus decreasing the levels of serum HBV-DNA and delaying the progression of cirrhosis. Although NA therapy is recommended for all patients with chronic HBV infection, regardless of the level of renal dysfunction, there is limited information on NA use in patients with chronic kidney disease. In addition, in patients with end-stage liver cirrhosis, hepatorenal syndrome can be fatal. Hence, we should take into account the stage of impaired renal function in patients with cirrhosis. The aims of this article are to review the epidemiology, clinical presentation, treatment, and prevention of HBV-associated nephropathy.

    DOI: 10.3390/diseases6020052

    PubMed

    researchmap

  • Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis. 査読 国際誌

    Toru Setsu, Satoshi Yamagiwa, Kentaro Tominaga, Naruhiro Kimura, Hiroki Honda, Hiroteru Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Shuji Terai

    Journal of gastroenterology and hepatology   33 ( 6 )   1286 - 1294   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND AIM: Mucosal-associated invariant T (MAIT) cells constitute a novel subset of innate-like T lymphocytes characterized by a semi-invariant T-cell receptor repertoire capable of recognizing bacterial products. Considering the abundance of MAIT cells in the liver and the possible association between bacterial infections and primary biliary cholangitis (PBC), we aimed to analyze the involvement of MAIT cells in the immunopathogenesis of PBC. METHODS: Peripheral blood and liver biopsy specimens were collected from 25 patients with PBC and 19 patients with chronic viral hepatitis. Surgically removed liver tissues distant from tumors in patients with metastatic liver tumors were used as controls. Mononuclear cells were separated using Ficoll gradient, and the expression of various markers was investigated by flow cytometry. Cytokine production was investigated using blood MAIT cells after stimulation by anti-CD3/CD28-coupled beads with/without interleukin-7 (IL-7). RESULTS: Mucosal-associated invariant T cells were significantly reduced in both the blood and liver of PBC patients compared with those in controls. MAIT cells in the blood of PBC patients expressed significantly lower levels of activation markers and IL-7 receptor. Moreover, MAIT cells in the blood of PBC patients showed impaired production of cytokines, especially tumor necrosis factor alpha, after in vitro stimulation with IL-7. Interestingly, even after biochemical responses were achieved by ursodeoxycholic acid treatment, the frequencies of MAIT cells did not fully recover to normal levels. CONCLUSIONS: These findings suggested that MAIT cells were activated, exhausted, and persistently depleted in PBC patients even after ursodeoxycholic acid treatment, possibly as a consequence of persistent liver inflammation.

    DOI: 10.1111/jgh.14076

    PubMed

    researchmap

  • A Case of Successful Treatment of Ruptured Pancreaticoduodenal Artery Aneurysm Caused by Celiac Artery Dissection. 査読

    Kimura N, Tsuchiya A, Nakamura A, Ueda M, Yoshikawa S, Hoshi T, Takano A, Takagi S, Miura T, Yamada S, Yanagi M, Tani T, Hirahara H

    Case reports in gastroenterology   12 ( 2 )   385 - 389   2018年5月

  • Possible involvement of chemokine C-C receptor 7−programmed cell death-1+ follicular helper T-cell subset in the pathogenesis of autoimmune hepatitis 査読

    Naruhiro Kimura, Satoshi Yamagiwa, Tomoyuki Sugano, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai

    Journal of Gastroenterology and Hepatology (Australia)   33 ( 1 )   298 - 306   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Blackwell Publishing  

    Background and Aim: Recent studies have demonstrated that B cells and follicular helper T (Tfh) cells, which are central regulators of humoral immune response, contribute to the development and progression of autoimmune diseases. Because Tfh cells can be divided into several subsets with distinct functional properties, this study aimed to examine the roles of different subsets of circulating Tfh cells in the immune pathogenesis of autoimmune hepatitis (AIH). Methods: Thirty-five patients with AIH, 28 patients with primary biliary cholangitis, 22 patients with chronic hepatitis B (CHB), and 44 health controls (HC) were enrolled. The frequencies of different Tfh subsets in the blood and liver were examined by flow cytometry and immunohistochemical staining. The function of circulating Tfh subsets was examined after in vitro stimulation. Results: In newly diagnosed AIH patients, the frequency of circulating chemokine C-C receptor 7−programmed cell death-1+ Tfh subset was significantly increased compared with that in CHB patients and HC, significantly correlated with clinical parameters, including serum IgG, prothrombin time and albumin levels, and significantly decreased after corticosteroid treatment. In the liver of AIH patients, the frequencies of activated Tfh subsets were significantly increased and positively correlated with those in the blood. Moreover, the ability to produce interleukin-21 and interleukin-17 from circulating Tfh cells was significantly increased in AIH patients compared with HC. Conclusions: These results significantly extend our understanding of Tfh subsets in AIH and suggest a potential role of dysregulated chemokine C-C receptor 7−programmed cell death-1+ Tfh subset in the pathogenesis and disease progression of AIH.

    DOI: 10.1111/jgh.13844

    Scopus

    PubMed

    researchmap

  • Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma 査読

    Hiroki Honda, Masaaki Takamura, Satoshi Yamagiwa, Takuya Genda, Ryoko Horigome, Naruhiro Kimura, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Yasunobu Matsuda, Toshifumi Wakai, Yutaka Aoyagi, Shuji Terai

    SCIENTIFIC REPORTS   7 ( 1 )   15485   2017年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Cell motility plays an important role in intrahepatic metastasis of hepatocellular carcinoma (HCC), and predicts poor prognosis in patients. The present study investigated the role of a disintegrin and metalloproteinases (ADAMs) in HCC, since these proteins are known to be associated with cell motility. We confirmed the expression of 12 ADAMs with putative metalloproteinase activity in HCC cells, and established a KYN-2 HCC cell line stably expressing short interfering RNA against ADAM21 to investigate the effect of ADAM21 deficiency on HCC cell motility and metastasis in vitro and in vivo. We also examined ADAM21 expression in a cohort of 119 HCC patients by immunohistochemistry. ADAM21 was overexpressed in KYN-2 cells, and its knockdown reduced invasion, migration, proliferation, and metastasis relative to controls. In clinical specimens, ADAM21 positivity was associated with vascular invasion, large tumor size, high histological grade, and lower overall and recurrence-free survival as compared to cases that were negative for ADAM21 expression. A multivariate analysis revealed that ADAM21 positivity was an independent risk factor for overall (P = 0.003) and recurrence-free (P = 0.001) survival. These results suggest that ADAM21 plays a role in HCC metastasis and can serve as a prognostic marker for disease progression.

    DOI: 10.1038/s41598-017-15800-z

    Web of Science

    PubMed

    researchmap

  • Usefulness of follicular helper T cell subset frequencies in the diagnosis of autoimmune hepatitis 査読

    Naruhiro Kimura, Satoshi Yamagiwa, Ryoko Horigome, Hiroteru Kamimura, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Shuji Terai

    HEPATOLOGY   66   687A - 688A   2017年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis 査読

    Toru Setsu, Satoshi Yamagiwa, Naruhiro Kimura, Hiroteru Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Shuji Terai

    HEPATOLOGY   66   166A - 166A   2017年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases 査読

    Kentaro Tominaga, Satoshi Yamagiwa, Toru Setsu, Naruhiro Kimura, Hiroki Honda, Hiroteru Kamimura, Yutaka Honda, Masaaki Takamura, Junji Yokoyama, Kenji Suzuki, Toshifumi Wakai, Shuji Terai

    BIOMEDICAL RESEARCH-TOKYO   38 ( 2 )   111 - 121   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BIOMEDICAL RESEARCH PRESS LTD  

    munity. Recent studies have demonstrated that MAIT cells might be implicated in inflammatory bowel diseases (IBDs), but their precise function in IBD remains to be elucidated. We investigated the possible involvement of MAIT cells in the immunopathogenesis of IBDs. Heparinized peripheral blood and biopsy specimens of the colon were collected from 25 patients with ulcerative colitis (UC), 15 patients with Crohn's disease (CD), and 19 heathy individuals. Lymphocytes were isolated from the blood and colon, and then MAIT cells were analyzed by flow cytometry. The frequency of MAIT cells was significantly lower in the blood of IBD patients compared to healthy donors and significantly higher in the inflamed colons compared to healthy colons (P = 0.001). Among the IBD patients, the frequency of MAIT cells in the blood and colon was correlated with disease activities. In vitro activated MAIT cells from IBD patients secreted significantly more tumor necrosis factor-alpha and interleukin-17 than those from healthy donors. These findings indicate that MAIT cells are activated in IBD patients, and their accumulation in the inflamed mucosa is correlated with disease activities.

    DOI: 10.2220/biomedres.38.111

    Web of Science

    PubMed

    researchmap

  • Biological significance of a disintegrin and metalloproteinase 21 expression in hepatocellular carcinoma 査読

    Masaaki Takamura, Hiroki Honda, Satoshi Yamagiwa, Naruhiro Kimura, Toru Setsu, Kentaro Tominaga, Hiroteru Kamimura, Takuya Genda, Yasunobu Matsuda, Toshifumi Wakai, Shuji Terai

    HEPATOLOGY   64   639A - 639A   2016年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • Possible involvement of activating follicular helper T cells in autoimmune hepatitis 査読

    Kimura Naruhiro, Yamagiwa Satoshi, Honda Hiroki, Setsu Toru, Tominaga Kentaro, Kamimura Hiroteru, Takamura Masaaki, Terai Shuji

    HEPATOLOGY   62   369A - 369A   2015年10月

     詳細を見る

    記述言語:英語  

    Web of Science

    researchmap

  • Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve 査読

    Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida

    HEPATOLOGY RESEARCH   44 ( 11 )   1056 - 1061   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    AimHepatocellular carcinoma (HCC) is frequently complicated with cirrhosis, and it is not unusual for treatment options to be limited as a result of pancytopenia due to hypersplenism. Partial splenic embolization (PSE) has been performed for thrombocytopenia resulting from hypersplenism. We studied the efficacy in terms of hepatic functional reserve and safety in patients who underwent concurrent transcatheter arterial chemoembolization (TACE) with PSE for HCC.
    MethodsThe study population consisted of 101 HCC patients with thrombocytopenia. Fifty-three patients were treated with concurrent TACE/PSE (PSE group), and the remaining 48 TACE patients without PSE (non-PSE group) were investigated hepatic functional reserve.
    ResultsPlatelet counts were significantly higher in the PSE group after 2 weeks, 2 months and 6 months after TACE than the non-PSE group. Child-Pugh score significantly deteriorated from 7.131.16 to 7.60 +/- 1.20 at 2 weeks, to 7.71 +/- 1.25 at 2 months, and 7.71 +/- 1.35 at 6 weeks after TACE in the non-PSE group. Hence, it worsened from 7.04 +/- 1.05 to 7.21 +/- 0.99 at 2 weeks temporally, but improved to 7.00 +/- 1.17 after 2 months and 6.70 +/- 1.16 at 6 weeks after TACE in the PSE group.
    ConclusionThrombocytopenia has been improved and treatment continued using concurrent PSE. In addition, hepatic functional reserve could be maintained even after treatment for HCC. Concurrent TACE and PSE for HCC with thrombocytopenia can be expected to help maintain hepatic reserve, and may contribute to improving the prognosis of HCC.

    DOI: 10.1111/hepr.12222

    Web of Science

    PubMed

    researchmap

  • Possible impairment of mucosal-associated invariant T cells in the liver of patients with primary biliary cirrhosis 査読

    Toru Setsu, Satoshi Yamagiwa, Kentaro Tominaga, Naruhiro Kimura, Hiroki Honda, Hiroteru Kamimura, Masaaki Takamura, Minoru Nomoto

    HEPATOLOGY   60   357A - 358A   2014年

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Distinctive phenotypic features of human mucosal-associated invariant T cells in the liver 査読

    Kentaro Tominaga, Toru Setsu, Satoshi Yamagiwa, Naruhiro Kimura, Hiroki Honda, Hiroteru Kamimura, Masaaki Takamura, Minoru Nomoto

    HEPATOLOGY   60   506A - 506A   2014年

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Branched-chain amino acids to tyrosine ratio (BTR) predicts intrahepatic distant recurrence and survival for early hepatocellular carcinoma 査読

    Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida

    Hepato-Gastroenterology   60 ( 128 )   2055 - 2059   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background/Aims: The Child-Pugh classification system is the most widely used system for assessing hepatic functional reserve in HCC treatment. In the Child-Pugh classification system, serum albumin levels are used to accurately assess the status of protein metabolism and nutrition. To date, a lack of attention has been given to amino acid metabolism. In the present study, we investigated whether the branched-chain amino acids to tyrosine ratio (BTR) as an indicator of amino acid metabolism can serve as both a prognostic factor for early HCC and a predictive factor for recurrence. Methodology: We conducted a cohort study of 50 patients with stage I/II HCC enrolled between May 2002 and December 2010. It was investigated whether BTR can serve as both a prognostic factor and a predictive factor for HCC recurrence. Results: Overall survival rates were significantly higher in patients with high baseline BTR than in those with low BTR. Multivariate analysis showed that both BTR and serum albumin were prognostic factors, and that BTR was the best predictive factor for recurrence. Conclusions: BTR was a prognostic factor for early HCC and the most predictive factor for intrahepatic distant recurrence and contributing factors for survival. © H.G.E. Update Medical Publishing S.A.

    DOI: 10.5754/hge13488

    Scopus

    PubMed

    researchmap

  • Case of cerebral lipiodol embolism after repeated transcatheter arterial chemoembolization of hepatocellular carcinoma 査読

    Toru Ishikawa, Tomoyuki Kubota, Hiroyuki Abe, Yuichiro Toduka, Ryoko Horigome, Yuhsuke Watanabe, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida, Masahisa Sato

    HEPATOLOGY RESEARCH   43 ( 11 )   1251 - 1252   2013年11月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/hepr.12074

    Web of Science

    PubMed

    researchmap

  • Radiofrequency ablation during continuous saline infusion can extend ablation margins 査読

    Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida

    WORLD JOURNAL OF GASTROENTEROLOGY   19 ( 8 )   1278 - 1282   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BAISHIDENG PUBL GRP CO LTD  

    AIM: To determine whether fluid injection during radiofrequency ablation (RFA) can increase the coagulation area.
    METHODS: Bovine liver (1-2 kg) was placed on an aluminum tray with a return electrode affixed to the base, and the liver was punctured by an expandable electrode. During RFA, 5% glucose; 50% glucose; or saline fluid was infused continuously at a rate of 1.0 mL/min through the infusion line connected to the infusion port. The area and volume of the thermocoagulated region of bovine liver were determined after RFA. The Joule heat generated was determined from the temporal change in output during the RFA experiment.
    RESULTS: No liquid infusion was 17.3 +/- 1.6 mL, similar to the volume of a 3-cm diameter sphere (14.1 mL). Mean thermocoagulated volume was significantly larger with continuous infusion of saline (29.3 +/- 3.3 mL) than with 5% glucose (21.4 +/- 2.2 mL), 50% glucose (16.5 +/- 0.9 mL) or no liquid infusion (17.3 +/- 1.6 mL). The ablated volume for RFA with saline was approximately 1.7-times greater than for RFA with no liquid infusion, representing a significant difference between these two conditions. Total Joule heat generated during RFA was highest with saline, and lowest with 50% glucose.
    CONCLUSION: RFA with continuous saline infusion achieves a large ablation zone, and may help inhibit local recurrence by obtaining sufficient ablation margins. RFA during continuous saline infusion can extend ablation margins, and may be prevent local recurrence. (C) 2013 Baishideng. All rights reserved.

    DOI: 10.3748/wjg.v19.i8.1278

    Web of Science

    PubMed

    researchmap

  • Prevalence of Howell-Jolly Bodies Caused by Partial Splenic Embolization for Portal Hypertension 査読

    Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida

    INTERNAL MEDICINE   52 ( 16 )   1765 - 1768   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objective Postsplenectomy sepsis (PSS) and overwhelming postsplenectomy infection (OPSI) following splenectomy or the development of hyposplenism are associated with a high mortality rate. The presence of Howell-Jolly bodies (HJBs) in peripheral erythrocytes is attracting attention as a parameter of hyposplenism. To date, whether HJBs appear following partial splenic embolization (PSE) has not been investigated. Therefore, we examined the prevalence of HJBs in patients who have undergone PSE.
    Methods Whether HJBs were present in 95 patients who underwent PSE between November 2007 and August 2012 was assessed.
    Results No serious complications occurred due to PSE; however, 17 of the 95 patients (17.89%) exhibited HJBs during the follow-up. The residual spleen volume and splenic infarction rate did not differ significantly compared to those observed in the HJB-negative group.
    Conclusion With the recent increase in the use of autoanalyzers, the opportunities to perform microscopic examinations have been decreasing. Therefore, the presence of HJBs, which can only be confirmed visually, may be overlooked, and the clinical significance of these bodies tends to be disregarded. However, the presence of HJBs is associated with a risk of PSS and OPSI due to hyposplenism. Because HJBs are common in the peripheral erythrocytes of patients who have undergone PSE, irrespective of the residual spleen volume or splenic infarction rate, the presence or absence of HJBs should be assessed visually. In HJB-positive patients, preventing serious infections, for example, by administering the pneumococcal vaccine, is important.

    DOI: 10.2169/internalmedicine.52.0407

    Web of Science

    PubMed

    researchmap

  • Rice Cake Ileus - A Rare and Ethnic but Important Disease Status in East-Southern Asia 査読

    Tomofumi Miura, Naruhiro Kimura, Junichiro Nakamura, Satoshi Yamada, Tsutomu Miura, Masahiko Yanagi, Yohei Ikeda, Satoshi Takaki, Yoshiko Tani, Takeshi Ito, Mamiko Nishihara, Toru Takahashi

    INTERNAL MEDICINE   50 ( 22 )   2737 - 2739   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Introduction Rice cake is a traditional but very popular food in Asia including Japan and has never been known as a cause of ileus. Rice cake is now becoming widespread in the United States and European countries along with other Japanese foods. We may encounter rice cake ileus all over the world. This study was aimed at characterizing the rice cake ileus.
    Methods We consecutively encountered 14 patients with rice cake ileus from April 2003 to October 2010 in our hospital. All of the characteristics of the cases were reviewed and analyzed.
    Results All patients had ingested rice cake by swallowing without chewing. It has most frequently occurred in January (57.1%). The main symptoms were abdominal colicky pain (100%) and nausea (85.7%) and physical findings included abdominal tenderness (100%) and muscular defense (28.6%). All patients improved by conservative therapy including fluid supply (100%), naso-gastric tube (28.6%) and long tube (28.6%) insertion. No patient needed emergency open surgery.
    Conclusion Rice cake ileus which is caused by swallowing the rice cake without chewing, frequently occurs in January, has previous history of abdominal surgery and shows high density intestinal contents on CT and only needs conservative therapy. Globalism in food culture may provide a new disease entity. Therefore, we should be aware of this type of ileus and be prepared to manage it appropriately.

    DOI: 10.2169/internalmedicine.50.6152

    Web of Science

    PubMed

    researchmap

▶ 全件表示

MISC

  • CONSIDERATION OF SERUM IGA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

    Kentaro Tominaga, Yuzo Kawata, Naruhiro Kimura, Takeshi Mizusawa, Hiroki Sato, Satoshi Ikarashi, Kazunao Hayashi, Kenichi Mizuno, Satoru Hashimoto, Atsunori Tsuchiya, Junji Yokoyama, Shuji Terai

    GASTROENTEROLOGY   156 ( 6 )   S847 - S847   2019年5月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:W B SAUNDERS CO-ELSEVIER INC  

    0

    Web of Science

    researchmap

  • 当院における高齢発症原発性胆汁性胆管炎患者の予後予測マーカーについて

    高村 昌昭, 木村 成宏, 薛 徹, 上村 博輝, 坂牧 僚, 横尾 健, 土屋 淳紀, 上村 顕也, 松田 康伸, 寺井 崇二

    肝臓   60 ( Suppl.1 )   A407 - A407   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 高齢肝癌症例におけるソラフェニブの効果と有用性

    横尾 健, 森田 真一, 木村 成宏, 薛 徹, 坂牧 僚, 上村 博輝, 上村 顕也, 土屋 淳紀, 高村 昌昭, 寺井 崇二

    日本消化器病学会雑誌   116 ( 臨増総会 )   A413 - A413   2019年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院における肝癌に対する放射線治療の検討

    柴田 理, 上村 顕也, 木村 成宏, 薛 徹, 横尾 健, 坂牧 僚, 上村 博輝, 土屋 淳紀, 高村 昌昭, 丸山 克也, 太田 篤, 海津 元樹, 青山 英史, 寺井 崇二

    日本消化器病学会雑誌   116 ( 臨増総会 )   A456 - A456   2019年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • Classification of Heterogeneous Hepatocellular Carcinoma Using Four Hepatic Progenitor Cell Markers and Three Serum Tumor Markers

    Atsunori Tsuchiya, Satoshi Seino, Yuichi Kojima, Naruhiro Kimura, Toru Setsu, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Kenya Kamimura, Masaaki Takamura, Shuji Terai

    HEPATOLOGY   68   545A - 546A   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • 当院における1型自己免疫性膵炎診療の現状と課題

    林 和直, 五十嵐 聡, 木村 成宏, 河久 順志, 高橋 一也, 冨永 顕太郎, 水野 研一, 橋本 哲, 横山 純二, 山際 訓, 寺井 崇二

    日本消化器病学会雑誌   115 ( 臨増総会 )   A299 - A299   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 当院における1型自己免疫性膵炎診療の現状と課題

    林和直, 五十嵐聡, 木村成宏, 河久順志, 高橋一也, 冨永顕太郎, 水野研一, 橋本哲, 横山純二, 山際訓, 寺井崇二

    日本消化器病学会雑誌(Web)   115   2018年

     詳細を見る

  • Frequency of CCR7(-)PD-1(+) follicular helper T cell subset as a possible diagnostic marker of autoimmune hepatitis

    Satoshi Yamagiwa, Naruhiro Kimura, Ryoko Horigome, Tomoyuki Sugano, Atsunori Tsuchiya, Kenya Kamimura, Masaaki Takamura, Hirokazu Kawai, Shuji Terai

    HEPATOLOGY   64   822A - 822A   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • 当院における自己免疫性肝炎の診断、予後について

    木村 成宏, 山際 訓, 菅野 智之, 倉岡 直亮, 本田 博樹, 上村 顕也, 土屋 淳紀, 高村 昌昭, 寺井 崇二

    肝臓   57 ( Suppl.1 )   A171 - A171   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 肝細胞癌におけるa disintegrin and metalloprotease 21発現の生物学的意義に関する検討

    本田 博樹, 高村 昌昭, 山際 訓, 玄田 拓哉, 木村 成宏, 薛 徹, 冨永 顕太郎, 上村 博輝, 松田 康伸, 若井 俊文, 寺井 崇二

    肝臓   57 ( Suppl.1 )   A247 - A247   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 【コランギオパチー】 免疫介在性コランギオパチー 原発性硬化性胆管炎

    山際 訓, 木村 成宏, 本田 博樹, 上村 博輝, 高村 昌昭, 寺井 崇二

    肝・胆・膵   71 ( 5 )   839 - 844   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)アークメディア  

    researchmap

  • 慢性腎臓病合併肝細胞癌の予後解析

    木村 成宏, 川合 弘一, 上村 博輝, 兼藤 努, 土屋 淳紀, 上村 顕也, 高村 昌昭, 山際 訓, 須田 剛士, 野本 実, 寺井 崇二

    日本消化器病学会雑誌   112 ( 臨増大会 )   A870 - A870   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 自己免疫性肝炎における肝内および末梢血中濾胞性ヘルパーT細胞の検討

    木村 成宏, 山際 訓, 本田 博樹, 薛 徹, 冨永 顕太郎, 上村 博輝, 高村 昌昭, 寺井 崇二

    肝臓   56 ( Suppl.1 )   A295 - A295   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • メチオニン・コリン欠乏食(MCD)誘発性脂肪肝炎に対するDPP-4阻害薬の効果

    山際 訓, 木村 成宏, 本田 博樹, 薛 徹, 冨永 顕太郎, 上村 博輝, 高村 昌昭, 寺井 崇二

    肝臓   56 ( Suppl.1 )   A549 - A549   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 炎症性腸疾患患者の末梢血および大腸粘膜におけるMAIT細胞に関する検討

    冨永 顕太郎, 山際 訓, 薛 徹, 木村 成宏, 鈴木 健司, 寺井 崇二

    日本消化器病学会雑誌   112 ( 臨増総会 )   A345 - A345   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)日本消化器病学会  

    researchmap

  • 慢性腎臓病合併肝細胞癌の予後解析

    木村 成宏, 川合 弘一, 上村 博輝, 兼藤 努, 土屋 淳紀, 上村 顕也, 田村 康, 高村 昌昭, 五十嵐 正人, 山際 訓, 須田 剛士, 野本 実, 青柳 豊

    肝臓   55 ( Suppl.2 )   A616 - A616   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本肝臓学会  

    researchmap

  • 詳細な画像検討を施行した肝原発神経内分泌腫瘍の一切除例

    木村 成宏, 吉田 俊明, 根本 健夫, 武田 敬子, 石原 法子, 坪野 俊広, 野本 実, 石川 達, 廣瀬 奏恵, 窪田 智之, 堀米 亮子, 本田 博樹, 岩永 明人, 関 慶一, 本間 照

    肝臓   55 ( 11 )   690 - 697   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本肝臓学会  

    症例は57歳女性.検診で肝腫瘤を指摘された.腹部CT,MRIで血管腫と診断したが,増大傾向を認めたため入院した.肝胆道系酵素,腫瘍マーカーの上昇は認めず,肝炎ウイルスは陰性であった.腫瘤はUSで不均一な低輝度,単純CTで低吸収,造影CTにて辺縁優位に濃染,MRIではT1強調像で低信号,T2強調像で内部に不均一な低信号を伴う高信号,肝細胞相では低信号となった.Single-level dynamic CT Angiography(CTA)ではリング状濃染を認め,造影効果は持続した.腫瘍内部は早期から濃染され速やかに消褪し,後期相では低吸収となった.診断に難渋したため肝腫瘍生検を施行した.その結果,免疫組織化学的にNCAM,chromogranin A,synaptophysinは陽性であり神経内分泌腫瘍と診断した.上部,下部消化管内視鏡検査,PET-CTも施行したが肝以外に異常所見を認めず,肝原発神経内分泌腫瘍と診断し,外科的切除を施行した.肝原発の神経内分泌腫瘍は非常にまれな疾患であるが,詳細な画像検査を施行し,若干の文献的考察を加え報告する.

    DOI: 10.2957/kanzo.55.690

    Scopus

    CiNii Article

    researchmap

  • 5 腹膜漿液性乳頭状腺癌が原発と推定された腫瘍塞栓性肺微小血管障害を来たした1剖検例(一般演題, 第53回下越内科集談会)

    田中 裕貴, 堀米 亮子, 寺田 正樹, 石原 法子, 本間 照, 木村 成宏, 本田 博樹, 岩永 明人, 窪田 智之, 関 慶一, 石川 達, 吉田 俊明

    新潟医学会雑誌   127 ( 7 )   387 - 387   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:新潟医学会  

    CiNii Article

    CiNii Books

    researchmap

  • 脳深部刺激装置(DBS)植え込み患者の転移性肝癌に対し経皮的ラジオ波焼灼術(RFA)を施行した1例

    石川 達, 廣澤 宏, 窪田 智之, 木村 成宏, 堀米 亮子, 本田 博樹, 岩永 明人, 関 慶一, 本間 照, 長谷川 伊織, 星 義弘, 吉田 俊明

    肝臓   54 ( 7 )   486 - 490   2013年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本肝臓学会  

    症例は73歳,男性.Parkinson病に対し脳深部刺激装置(Deep Brain Stimulators;DBS)を前胸部へ挿入.2010年8月に当院外科で直腸癌に対し低位前方切除術施行.2012年2月のCTにてS4-8の肝転移病変を指摘され,RFA目的に当科入院となった.DBSは治療前にRFAの高周波による誤作動を防ぐために医師用プログラマーにて電源OFFとした.治療中はバイタルサインと患者状態の観察を注意深く行い,Parkinson病の症状である振戦などが出現した場合すぐに対応できるように医師用プログラマーも準備した.治療中には振戦などは出現せず,安全に治療することができた.RFA後,電源ONとし,出力も2.2 vへ変更した.さらにリード抵抗も測定し,治療前と測定値に大きな変化がないことを確認した.肝悪性腫瘍患者の高齢化が進行してきており,今後脳深部刺激装置植え込み患者も増加すると推定される.このような患者で,局所治療の適応がある場合には,厳重なリスク管理を行う事により,RFAを行うことが必要である.&lt;br&gt;

    DOI: 10.2957/kanzo.54.486

    Scopus

    CiNii Article

    researchmap

  • 肝細胞癌に対する部分的脾動脈塞栓術併用肝動脈化学塞栓療法の臨床的意義

    石川 達, 窪田 智之, 木村 成宏, 堀米 亮子, 本田 博樹, 岩永 明人, 関 慶一, 本間 照, 吉田 俊明

    日門亢会誌   19 ( 4 )   179 - 181   2013年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本門脈圧亢進症学会  

    血小板減少を伴う肝細胞癌に対し,部分的脾動脈塞栓術(Partial splenic arterial embolization: PSE)と肝動脈化学塞栓療法(transcatheter arterial chemoembolization: TACE)を同時施行した症例の検討を行った.対象は血小板減少を伴う肝細胞癌症例に対し,TACEと同時にPSEを施行した術前血小板数5万/&amp;mu;l以下の23症例である.平均脾梗塞率は55.19%であり,術前平均血小板値は4.41万/&amp;mu;lで,術後平均血小板値は7.58万/&amp;mu;lに上昇した.血小板の上昇により,RFAを含めた穿刺治療は可能となった.血小板減少のためにTACE,RFAが困難な進行肝細胞癌症例に対し,PSEを同時併用することで,血小板を増加させ,治療を継続することができ,集学的治療の一環としてのPSEの有用性が示唆された.

    DOI: 10.11423/jsph.19.179

    CiNii Article

    researchmap

  • 36 進行胃癌に併発し診断に苦慮した肝腫瘍の1例(I.一般演題, 第36回リバーカンファレンス)

    川田 雄三, 中村 潤一郎, 木村 成宏, 西垣 祐紀, 嘉戸 慎一, 高野 明人, 山田 聡志, 三浦 努, 柳 雅彦, 内藤 哲也

    新潟医学会雑誌   126 ( 11 )   641 - 641   2012年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:新潟医学会  

    CiNii Article

    CiNii Books

    researchmap

  • 抗血小板薬による消化管出血を契機として発症した虚血性心疾患の2例

    目崎 直実, 三浦 智史, 木村 成宏, 中村 潤一郎, 山田 聡志, 三浦 努, 柳 雅彦, 高橋 達

    日本腹部救急医学会雑誌 = Journal of abdominal emergency medicine   32 ( 3 )   657 - 661   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本腹部救急医学会  

    抗血小板薬内服中の消化管出血が虚血性心疾患を顕在化させた2例を経験した。症例1は64歳男性。クロピドグレル内服中に吐下血をきたした。出血性胃潰瘍に対し内視鏡的止血術施行後も心窩部不快感が持続し諸検査で急性心筋梗塞と診断した。心臓CTや冠動脈造影で左前下行枝と右冠動脈に狭窄を認め経皮的冠動脈形成術を施行し再発なく経過している。症例2は80歳男性。低用量アスピリン内服中に血便をきたした。高度の貧血を認め,狭心症発作をきたした。心筋シンチグラフィで前壁中隔の虚血と診断した。高齢のため血圧管理のみで再発なく経過観察している。今後ますます増加が予想される抗血小板薬による消化管出血は重要な問題であり,プロトンポンプ阻害薬やH. pylori除菌療法による予防が推奨される。また,急激な貧血の進行は虚血性心疾患の発生閾値を低下させるため,抗血小板薬起因性消化管出血を診る際には虚血性心疾患発症のリスクをつねに念頭に置く必要がある。

    DOI: 10.11231/jaem.32.657

    CiNii Article

    CiNii Books

    researchmap

▶ 全件表示

共同研究・競争的資金等の研究

  • 非アルコール性脂肪肝炎の病態を制御する肝臓由来の悪玉細胞外小胞の同定と治療法開発

    研究課題/領域番号:22H03055

    2022年4月 - 2025年3月

    制度名:科学研究費助成事業

    研究種目:基盤研究(B)

    提供機関:日本学術振興会

    寺井 崇二, 渡邉 雄介, 酒井 規裕, 阿部 寛幸, 土屋 淳紀, 木村 成宏

      詳細を見る

    配分額:17550000円 ( 直接経費:13500000円 、 間接経費:4050000円 )

    researchmap

  • 胆汁性硬化性胆管炎における制御性T細胞を介した病態制御機構の解明と治療方法の確立

    研究課題/領域番号:22K16036

    2022年4月 - 2025年3月

    制度名:科学研究費助成事業

    研究種目:若手研究

    提供機関:日本学術振興会

    木村 成宏

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    researchmap